All News

Millions of individuals gain access to HIV treatment, but there are significant gaps that need to be addressed to end the epidemic.

Patients with severe psoriasis were 64% more likely to develop diabetes than control patients.

A new system allows researchers to test multiple drug combinations in cultured cancer stem cells from patients.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Synthetic cannabis-like therapy dronabinol associated with a lower overall apnea/hypopnea index compared with placebo.

Multiple sclerosis researchers actively seek new agents than can promote repair and remyelination.

In a world where we are bombarded with various diets, what does the evidence say?

New Hampshire is seeking to join the list of states allowing pharmacists to provide contraception to women without a prescription.

Apple announces a study to investigate whether their Apple Watch can detect afib in patients.

The FDA has extended the approval of raltegravir (Isentress, Merck), an integrase inhibitor for use in combination with other antiretroviral agents, for the treatment of HIV-1 in newborn infants weighing at least 2 kg.

Americans are getting tested and diagnosed with HIV sooner after infection, according to a recently-published CDC Vital Signs report.

An infant’s sex-specific gut microbiome following maternal asthma during pregnancy may influence their risk of developing childhood asthma.

Currently, more women practice in pharmacy than men, and it is expected that the number of women practicing will continue to rise.

High oncology drug costs could impact adherence to cancer treatment.

Children and young adults with diabetes 8 times more likely to experience cardiovascular mortality.

Closing gaps in testing at-risk populations could increase HIV diagnoses.

Biotin interference in lab tests has resulted in at least 1 patient death.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Trelegy Ellipta is a combination of an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting beta2-adrenergic agonist for chronic obstructive pulmonary disease.

Experimental drug found to reduce inflammation and promote remyelination in patients with relapsing-remitting multiple sclerosis.

A lack of physical activity leads to a higher risk of depression among patients with rheumatic diseases.

Here are tips on managing people well, ensuring fairness, and behaving like a boss who people actually respect and want to emulate.

Here are some ways to cope with any stress or challenges that community pharmacy may bring.

Currently, the plan is to role out Viagra Connect in the first or second quarter of 2018.

The FDA is monitoring reports of adverse events associated with biotin interference with laboratory tests and will update the public if significant new information becomes available.

Increasing collaboration among providers could improve medication adherence and patient outcomes.